z-logo
Premium
A phase I clinical trial of avelumab in combination with decitabine as first line treatment of unfit patients with acute myeloid leukemia
Author(s) -
Zheng Hong,
Mineishi Shin,
Claxton David,
Zhu Junjia,
Zhao Chenchen,
Jia Bei,
Ehmann W. Christopher,
Rybka Witold B.,
Naik Seema,
Songdej Natthapol,
Drabick Joseph J.,
Hohl Raymond J.
Publication year - 2021
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.26043
Subject(s) - medicine , gerontology , library science , computer science

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom